Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

France Pharmaceutical Packaging Market

ID: MRFR/PCM/44142-HCR
111 Pages
Snehal Singh
Last Updated: April 06, 2026
France Pharmaceutical Packaging Market Research Report: By Product Outlook (Vials, Bottles and Jars, Cartridges and Syringes, Ampoules), By Material Type Outlook (Type I, Type II, Type III), andBy Application Outlook (Generic Drugs, Branded Drugs, Biological Drugs)- Forecast to 2035.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Packaging & Transport, BY Formulation Type (USD Million)
      1. 4.1.1 Solid
      2. 4.1.2 Liquid
      3. 4.1.3 Semi-Solid
      4. 4.1.4 Gaseous
    2. 4.2 Packaging & Transport, BY Material Type (USD Million)
      1. 4.2.1 Plastic
      2. 4.2.2 Glass
      3. 4.2.3 Metal
      4. 4.2.4 Paper
    3. 4.3 Packaging & Transport, BY Packaging Type (USD Million)
      1. 4.3.1 Bottles
      2. 4.3.2 Blisters
      3. 4.3.3 Syringes
      4. 4.3.4 Pouches
      5. 4.3.5 Boxes
    4. 4.4 Packaging & Transport, BY End Use (USD Million)
      1. 4.4.1 Pharmaceutical Companies
      2. 4.4.2 Contract Packaging Organizations
      3. 4.4.3 Research Laboratories
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Packaging & Transport
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Packaging & Transport
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Amcor (AU)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 West Pharmaceutical Services (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Becton Dickinson (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Gerresheimer (DE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Schott AG (DE)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 AptarGroup (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Catalent (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Sanner (DE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 MediPharm (CA)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 FRANCE MARKET ANALYSIS BY FORMULATION TYPE
    3. 6.3 FRANCE MARKET ANALYSIS BY MATERIAL TYPE
    4. 6.4 FRANCE MARKET ANALYSIS BY PACKAGING TYPE
    5. 6.5 FRANCE MARKET ANALYSIS BY END USE
    6. 6.6 KEY BUYING CRITERIA OF PACKAGING & TRANSPORT
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF PACKAGING & TRANSPORT
    9. 6.9 DRIVERS IMPACT ANALYSIS: PACKAGING & TRANSPORT
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: PACKAGING & TRANSPORT
    11. 6.11 SUPPLY / VALUE CHAIN: PACKAGING & TRANSPORT
    12. 6.12 PACKAGING & TRANSPORT, BY FORMULATION TYPE, 2024 (% SHARE)
    13. 6.13 PACKAGING & TRANSPORT, BY FORMULATION TYPE, 2024 TO 2035 (USD Million)
    14. 6.14 PACKAGING & TRANSPORT, BY MATERIAL TYPE, 2024 (% SHARE)
    15. 6.15 PACKAGING & TRANSPORT, BY MATERIAL TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 PACKAGING & TRANSPORT, BY PACKAGING TYPE, 2024 (% SHARE)
    17. 6.17 PACKAGING & TRANSPORT, BY PACKAGING TYPE, 2024 TO 2035 (USD Million)
    18. 6.18 PACKAGING & TRANSPORT, BY END USE, 2024 (% SHARE)
    19. 6.19 PACKAGING & TRANSPORT, BY END USE, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 France MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY FORMULATION TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY MATERIAL TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY PACKAGING TYPE, 2025-2035 (USD Million)
      4. 7.2.4 BY END USE, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

France Packaging & Transport Market Segmentation

Packaging & Transport By Formulation Type (USD Million, 2025-2035)

  • Solid
  • Liquid
  • Semi-Solid
  • Gaseous

Packaging & Transport By Material Type (USD Million, 2025-2035)

  • Plastic
  • Glass
  • Metal
  • Paper

Packaging & Transport By Packaging Type (USD Million, 2025-2035)

  • Bottles
  • Blisters
  • Syringes
  • Pouches
  • Boxes

Packaging & Transport By End Use (USD Million, 2025-2035)

  • Pharmaceutical Companies
  • Contract Packaging Organizations
  • Research Laboratories